Clinical Trial Diversity and Accessibility: Managing the Data Demands
As the pharmaceutical industry seeks to improve health outcomes globally, a critical area of investment is increasing participant diversity. [...]
As the pharmaceutical industry seeks to improve health outcomes globally, a critical area of investment is increasing participant diversity. [...]
Life sciences teams are more decentralized than ever, yet the need for speed persists. Even before the pandemic, the ability to bring together [...]
Chris Moxham, Ph.D., is the Chief Scientific Officer at Fulcrum Therapeutics, an innovative biotech addressing the causes of genetically defined [...]
2020 provided a perfect storm for cybercriminals to extort record amounts from vulnerable businesses. Recent reporting has identified life sciences companies as being particularly attractive to target [...]
SAS JMP is a statistical analysis and visualization tool popular in the life sciences industry to generate insight from large datasets. For more than a decade our customers have been leveraging Egnyte [...]
According to the FDA, 30 percent of clinical trials are flagged for data-integrity violations (i.e. missing source data and corrupted audit trails). The patchwork of evolving regulations, as well as relying [...]
Today marks the release of Egnyte for Life Sciences, a unified data collaboration platform to serve those advancing the science of health. In recent years, Egnyte’s team of industry veterans has listened [...]
With telemedicine, cloud storage, and electronic record-keeping on the rise, patient data has found itself a common target for hackers. As a result, healthcare organizations must adapt and become even [...]
The goal of every life sciences company is to improve the lives of patients by getting their product to market. To do so often requires successfully completing a clinical trial. It goes without saying, [...]
In an earlier blog, Collaboration in the Modern Biotech Era, we explored the scope, dynamics, and complexity of collaboration in modern biotech and how “…these external partnerships have made the life [...]